Search
for
Sort by
Research 31–60 of 206
- Sorafenib-induced Facial Acneiform Eruption
- Activity of Sorafenib against Desmoid Tumor/Deep Fibromatosis
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Telocytes in human skin – are they involved in skin regeneration?
- The Harmonies Played by TGF-β in Stem Cell Biology
- The Pathogenesis of Primary Cicatricial Alopecias
- Hierarchical patterning modes orchestrate hair follicle morphogenesis
- Drug-Induced Skin, Nail and Hair Disorders
- Skin Adipocyte Stem Cell Self-Renewal Is Regulated by a PDGFA/AKT-Signaling Axis
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Extracellular vesicle-based drug overview: research landscape, quality control and nonclinical evaluation strategies
- Adverse effects of common medications on male fertility
- Costunolide—A Bioactive Sesquiterpene Lactone with Diverse Therapeutic Potential
- Hair Depigmentation Is a Biological Readout for Pharmacological Inhibition of KIT in Mice and Humans
- Graft-versus-host disease
- Hair disorders in patients with cancer
- Drug-induced acne
- Premature graying of hair
- Alopecia in patients treated with molecularly targeted anticancer therapies
- Primary cicatricial alopecia: Recent advances in understanding and management
- Drug repositioning: current approaches and their implications in the precision medicine era
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- Drug Repurposing - Hypothesis, Molecular Aspects and Therapeutic Applications
- Platelet-derived growth factor signaling modulates adult hair follicle dermal stem cell maintenance and self-renewal
- Hair Biology
- Dormancy in the stem cell niche
- Experimental and thermodynamic analyses of supercritical CO2-Solubility of minoxidil as an antihypertensive drug
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- [4-t-Butylphenyl]-N-(4-imidazol-1-yl phenyl)sulfonamide (ISCK03) inhibits SCF/c-kit signaling in 501mel human melanoma cells and abolishes melanin production in mice and brownish guinea pigs
- Topically used herbal products for the treatment of hair loss: preclinical and clinical studies